![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 9/00 | (2006.01) |
A61K 9/08 | (2006.01) | ||
A61K 31/485 | (2006.01) | ||
A61K 39/395 | (2006.01) | ||
A61K 47/18 | (2017.01) | ||
A61K 47/26 | (2006.01) | ||
A61P 19/00 | (2006.01) | ||
A61P 19/02 | (2006.01) | ||
A61P 25/00 | (2006.01) | ||
A61P 29/00 | (2006.01) | ||
A61P 37/02 | (2006.01) | ||
A61P 37/06 | (2006.01) | ||
C07K 16/24 | (2006.01) |
(11) | Number of the document | 3756652 |
(13) | Kind of document | T |
(96) | European patent application number | 20184418.0 |
Date of filing the European patent application | 2011-01-07 | |
(97) | Date of publication of the European application | 2020-12-30 |
(45) | Date of publication and mention of the grant of the patent | 2022-06-22 |
(46) | Date of publication of the claims translation | 2022-09-12 |
(30) | Number | Date | Country code |
29322710 P | 2010-01-08 | US |
(72) |
DIX, Daniel, B , US
GRAHAM, Kenneth, S. , US
KAMEN, Douglas, E. , US
WALSH, Scott, M. , US
|
(73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591-6707,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Stabilizuotos kompozicijos, kurių sudėtyje yra interleukino-6 (IL6R) receptorius blokuojantys antikūnai |
STABILIZED FORMULATIONS CONTAINING ANTI-INTERLEUKIN-6 RECEPTOR (IL-6R) ANTIBODIES |
Payment date | Validity (years) | Amount | |
2024-12-18 | 15 | 289.00 EUR |
2026-01-07 |